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Abstract
Background: Reference genes, which are often referred to as housekeeping genes are frequently used to
normalize mRNA levels between different samples in quantitative reverse transcription polymerase chain reaction
(qRT-PCR). The selection of reference genes is critical for gene expression studies because the expression of
these genes may vary among tissues or cells and may change under certain circumstances. Here, a systematic
evaluation of six putative reference genes for gene expression studies in human hepatocellular carcinoma (HCC)
is presented.
Methods:  Six genes, beta-2-microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
hydroxymethyl-bilane synthase (HMBS), hypoxanthine phosphoribosyl-transferase 1 (HPRT1), succinate
dehydrogenase complex, subunit A (SDHA) and ubiquitin C (UBC), with distinct functional characteristics and
expression patterns were evaluated by qRT-PCR. Inhibitory substances in RNA samples were quantitatively
assessed and controlled using an external RNA control. The stability of selected reference genes was analyzed
using both geNorm and NormFinder software.
Results: HMBS and GAPDH were identified as the optimal reference genes for normalizing gene expression data
between paired tumoral and adjacent non-tumoral tissues derived from patients with HCC. HMBS, GAPDH and
UBC were identified to be suitable for the normalization of gene expression data among tumor tissues; whereas
the combination of HMBS, B2M, SDHA and GAPDH was suitable for normalizing gene expression data among five
liver cancer cell lines, namely Hep3B, HepG2, HuH7, SK-HEP-1 and SNU-182. The determined gene stability was
increased after exclusion of RNA samples containing relatively higher inhibitory substances.
Conclusion: Of six genes studied, HMBS was found to be the single best reference gene for gene expression
studies in HCC. The appropriate choice of combination of more than one reference gene to improve qRT-PCR
accuracy depends on the kind of liver tissues or cells under investigation. Quantitative assessment and control of
qRT-PCR inhibitors using an external RNA control can reduce the variation of qRT-PCR assay and facilitate the
evaluation of gene stability. Our results may facilitate the choice of reference genes for expression studies in HCC.
Published: 27 November 2008
BMC Cancer 2008, 8:350 doi:10.1186/1471-2407-8-350
Received: 27 March 2008
Accepted: 27 November 2008
This article is available from: http://www.biomedcentral.com/1471-2407/8/350
© 2008 Cicinnati et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
Page 2 of 12
(page number not for citation purposes)
Background
Real-time quantitative reverse transcription (qRT)-
polymerase chain reaction (PCR) is a rapid, sensitive and
reliable method for gene expression studies. It is inher-
ently an indirect method of measurement, and variabili-
ties exist in the various steps of the qRT-PCR which may
lead to severe misinterpretation of the results. The latter
may be due to different amounts and quality of starting
material, variable enzymatic efficiencies (i.e. efficiency of
retrotranscription from RNA to complementary DNA
(cDNA), and PCR efficiency) between samples and runs,
operator errors, and differences between tissues or cells in
overall transcriptional activity [1,2]. Thus, proper normal-
ization strategy is necessary for reliable quantitative infor-
mation to be extracted from this variable system.
Various strategies have been explored in an attempt to
normalize these variations, and it is generally accepted
that gene-expression levels should be normalized by care-
fully selected and stably expressed reference genes [2-4].
The success of this procedure is highly dependent on the
choice of the appropriate reference genes. An ideal refer-
ence gene should be unaffected by the experimental con-
ditions and should have low variation in gene expression.
Otherwise, the detection of small changes becomes unfea-
sible, producing results that may be entirely incorrect [5].
Several reports have provided the evidence that the expres-
sion of most commonly used reference genes varies
among tissues or cells and may also change under certain
environmental circumstances [6-11]. For instance, a
recent report indicated the de-regulation of common ref-
erence genes in hepatocellular carcinoma (HCC) arising
from hepatitis C virus (HCV) infected liver [12]. There-
fore, it is critical to perform preliminary evaluation stud-
ies, aimed at identifying the most stably expressed
reference genes in individual tissues and distinct circum-
stances for each single experiment.
HCC is the sixth most frequently diagnosed cancer and
the third most common cause of cancer mortality in the
world [13], but the molecular mechanisms of hepatocar-
cinogenesis, including gene expression variation, are not
well understood. Therefore, the number of studies assess-
ing global gene expression profiles of HCC has increased
exponentially in recent years [14-20], and the identifica-
tion of optimal reference genes is necessary for correct
gene expression profiling of HCC. In the current study, we
validated the stability of six putative reference genes in
liver cancer cell lines, tumoral tissues and adjacent non-
tumoral tissues from 20 HCC patients. Two algorithms
based on different strategies, geNorm  and  NormFinder,
were used for data analysis.
Methods
Primer design
Primers for RT-PCR assays of HMBS  and  UBC  were
designed using Primer Express v2.0 (Applied Biosystems,
Foster City, California, USA). Primer sequences for B2M,
GAPDH, HPRT1 and SDHA were obtained from the real-
time PCR primer and probe database (RTPrimerDB) [21].
Special attention was given to primer length, annealing
temperature, base composition and 3'-end stability. To
ensure optimal DNA polymerization efficiency, amplicon
length ranged between 69 and 113 bp. Exon and intron
boundaries were determined aligning primers with corre-
sponding human genomic sequences downloaded from
GenBank http://www.ncbi.nlm.nih.gov/Genbank. RT-
PCR primers for each gene were located on different exons
or directly spanning exon-exon boundaries of the
genomic sequence to minimize amplification from any
contaminating genomic DNA that may remain following
DNase treatment. To ensure that gene transcripts used as
standards display a similar secondary structure with native
RNA, primers for cloning were designed to have binding
sites located at least 20 nucleotides external to the binding
sites of primers for assays. The sequences of primers for
cloning and the length of amplicons are shown in Supple-
mentary table 1 in additional file 1.
Samples
Human liver cancer cell lines Hep3B, HepG2, SK-HEP-1
and SNU-182 were obtained from the American Type Cul-
ture Collection (ATCC, Manassas, USA). Human HCC cell
line HuH7 was a kind gift from Dr. Brigitte Pützer. Hep3B,
HepG2, HUH7 and SK-HEP-1 were grown in DMEM
medium (high glucose, with glutamine and sodium pyru-
vate) supplemented with 10% (v/v) heat-inactivated fetal
bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml
streptomycin (all from PAA Laboratories Pasching, Aus-
tria), and 0.1 mM GIBCO™ MEM Non Essential Amino
Acids (Invitrogen Corporation, Carlsbad, CA). SNU-182
was grown in RPMI 1640 medium containing 1 mM
sodium pyruvate, 2 mM L-glutamine, 4500 mg/L glucose,
10 mM HEPES, and 1500 mg/L sodium bicarbonate, sup-
plemented with 10% (v/v) heat-inactivated FBS, 100 U/
ml penicillin and 100 μg/ml streptomycin (all from PAA
Laboratories). Stock cultures were maintained at 37°C in
a humidified, 5% CO2 incubator and were routinely pas-
saged at 3 to 4 day intervals. Tumoral and non-tumoral
liver tissues were obtained from 20 patients with HCC
undergoing liver resection. Most of those were paired
tumoral and adjacent non-tumoral tissues. All tissue sam-
ples were snap frozen in liquid nitrogen and stored till use
at -80°C. The study was approved by the local ethics com-
mittee and all patients provided written informed con-
sent. Detailed information regarding cell lines, patients
and tissue samples is shown in Supplementary tables 2
and 3 in additional file 1.BMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
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Total RNA isolation and characterization
Total RNA was extracted using the miRNeasy Mini Kit
(Qiagen, Hilden, Germany), according to the manufac-
turer's instructions. Genomic DNA was eliminated by a
DNase-on-column treatment with RNase-free DNase set
(Qiagen). The purity of extracted RNA was assessed by
measuring the optical density (OD) at wavelengths of 230
nm, 260 nm and 280 nm using a quartz cuvette with
Eppendorf Biophotometer (Eppendorf, Hamburg, Ger-
many). Absorbance ratio at 260/280 nm and 260/230 nm
was used to assess the purity of the RNA samples. The
integrity and quantity of extracted RNA were assessed by
evaluating the capillary electrophoresis trace with Agilent
2100 bioanalyzer (Agilent Technologies, Waldbronn,
Germany). The integrity of the samples was determined
by RNA integrity number (RIN) algorithm, which assigns
a score from 10 to 1, where level 10 represents a com-
pletely intact RNA, and level 1 represents a highly
degraded RNA [22]. Total RNA from cell lines was
extracted at the exponential growing phase. Liver tissue
samples were disrupted and homogenized in QIAzol lysis
reagent with TissueRuptor (Qiagen) for total RNA isola-
tion.
Construction of absolute standard curves
In vitro transcripts of each gene were generated as stand-
ards. RT-PCR products of each gene were purified with
Wizard® SV Gel and PCR Clean-Up System (Promega Cor-
poration, Madison, WI, USA), and then cloned with
PGEM®-T easy vector system (Promega), according to the
manufacturer's instructions. Plasmid DNA was isolated
and purified with Wizard® plus SV Minipreps DNA purifi-
cation system (Promega). The orientation and sequence
of the inserts were confirmed by restriction endonuclease
digestion with EcoRI (Roche Molecular Biochemicals,
Mannheim, Germany) followed by agarose gel electro-
phoresis with ethidium bromide staining, and gene
sequencing with BigDye® Terminator v1.1 Cycle Sequenc-
ing Kit (Applied Biosystems, Foster City, CA, USA) using
the T7 Promoter Primer (Promega). Bacterial clones with
correct inserts were cultured again for isolation and puri-
fication of plasmid DNA with PureYield™ Plasmid
Midiprep System (Promega). Plasmid DNA was linearized
with restriction endonuclease SaI I (Roche) or NcoI
(Promega) and transcribed into RNA with MEGAscript® T7
or Sp6 kit (Ambion, Austin, TX, USA). Transcripts were
purified with MEGAclear™ kit (Ambion) and plasmid
DNA was eliminated by DNase treatment before and after
the purification of the transcripts with TURBO DNase I
(Ambion) and TURBO DNA-free™ kit (Ambion) respec-
tively. DNase treated samples were desalted with DNase
inactivation reagent included in TURBO DNA-free™ kit.
The quantity and quality of the transcripts were evaluated
with Eppendorf Biophotometer (Eppendorf), denatured
agarose gel electrophoresis and Agilent 2100 bioanalyzer
(Agilent). Five points of 10-fold serial dilution of each
transcript were used to build the standard curve for each
gene. The copy number range of each standard curve was
set according to the approximate expression level of the
individual gene determined by preliminary experiments
and encompassed the copy number range of the genes in
the samples. The copy numbers of the standards are
shown in Supplementary table 4 in additional file 1.
qRT-PCR inhibitor detection
qRT-PCR inhibitor was detected in each sample and
standard using Alien® QRT-PCR Inhibitor Alert (Strata-
gene, La Lolla, CA, USA), according to the manufacturer's
instructions. Briefly, each sample was spiked with
105copies of alien RNA transcript, an in-vitro transcribed
RNA being non-homologous to the sequences currently
available in GenBank. Increases in the threshold cycle (Ct)
value for amplification of alien RNA in samples were com-
pared with alien RNA alone and calculated to determine
the presence of inhibitory substances in the samples [23].
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR (qRT-PCR) was performed
with the SYBR Green QuantiTect RT-PCR Kit (Qiagen),
according to the manufacturer's instructions. For each
sample, 20 ng total RNA was used in the assay and all the
genes were tested with the same panel of RNA samples. RT
negative reactions were performed for standards and sam-
ple RNA. All standards and samples were run in duplicate
on 96-well reaction plates with the iQ™5 Multicolor Real-
Time PCR Detection System (Bio-Rad, Hercules, CA,
USA). Reactions were prepared in a total volume of 25 μl
containing 20 ng RNA in 5 μl volume, 1.25 μl of each 10
μM primer (500 nM), 12.5 μl of SYBR Green master mix,
0.25 μl of RT mix and 4.75 μl RNase/DNase-free sterile
water. No template controls were run for each master mix
and primer pair. After performing preliminary gradient
real-time RT-PCR assays, the optimal annealing tempera-
ture for all the primer pairs resulted to be 56.4°C. At this
temperature the lowest Ct value was generated as well as a
sharp melting peak, with no amplification of non-specific
products or primer-dimer artifacts (see Additional file 2,
3, 4, 5, 6, 7). The conditions of reverse transcription and
primer concentrations were set according to the recom-
mendations in the manufacturer's instructions and con-
firmed by preliminary experiments which generated
correlation coefficient (R2) of each standard curve above
0.99. The cycle conditions were as follows: reverse tran-
scription at 50°C for 30 min, DNA polymerase activation
and RT enzyme inactivation at 95°C for 15 min, followed
by 40 cycles of denaturation at 94°C for 15 s, primer
annealing at 56.4°C for 30 s, elongation at 72°C for 30 s.
The data collection step was performed at a temperature
that was 3°C lower than the melting temperature of each
amplicon and higher than that of primer-dimers of eachBMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
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primer pair. This cycle was followed by a melting curve
analysis, ranging from 55°C to 95°C, with temperature
increasing steps of 0.5°C every 10 s. Baseline and thresh-
old values were automatically determined for all plates
using the Bio-Rad iQ5 Software 2.0. The obtained data
were analyzed using geNorm  (version 3.5, written by
Vandesompele J. et al) and NormFinder software (written
by Andersen C.L. et al).
Results and discussion
Six putative reference genes from different abundance and
functional classes were selected for evaluation: B2M,
GAPDH,  HMBS,  HPRT1,  SDHA, and UBC  (Table 1).
Ribosome RNAs, like 28s rRNA and 18s rRNA were not
included in this study, because imbalance between rRNA
and mRNA fractions has been observed and rRNA tran-
scription is affected by biological factors and drugs [24-
27]. Gene sequence information deposited in GenBank
under the Accession Numbers was used to design RT-PCR
primers (Table 2). The qRT-PCR efficiency for each single
primer pair was determined in real-time RT-PCR using
serial 10-fold dilutions of in vitro transcripts of each gene.
Expression patterns of the six reference genes have been
subsequently evaluated in different sample groups.
RNA quantity and quality determination
All RNA samples were examined for their purity, integrity
and concentration. The absorbance ratio at 260/280 nm
of all the samples were all over 2.0, except for one sample
with a ratio of 1.85, indicating all the samples were free
from proteins potentially accumulating during the RNA
extraction procedure. The absorbance ratios at 260/230
nm were 0.43 ~2.23, indicating possible contamination
of some samples with carbohydrates, peptides, phenols or
aromatic compounds [28]. Although samples with a low
OD 260/230 ratio may interfere with downstream process
like RT-PCR [28], only a few studies using RT-PCR meth-
ods have taken the OD 260/230 ratio into consideration
when evaluating RNA sample purity. In addition, there is
no generally accepted cutoff value of OD 260/230 ratio
that allows researchers to determine the suitability of a
sample to be used in qRT-PCR. Thus, RNA samples were
additionally subjected to qRT-PCR inhibitor detection for
the mining of the relationship between OD 260/230 ratio
and qRT-PCR inhibition. All RNA samples were deter-
mined to be intact or to have mild loss of integrity (RIN >
6.5) using the RIN algorithm [22]. A RIN higher than 5
was recommended as good total RNA quality and a RIN
higher than 8 as perfect total RNA quality for downstream
qRT-PCR application [29]. Therefore, the integrity of all
RNA samples was suitable for the use in our experiments.
The absorbance ratio at 260/280 nm, 260/230 nm and
RIN are shown in Supplementary table 5 in additional file
1.
Presence of qRT-PCR inhibitors in purified RNA samples
Increases of the Ct value (ΔCt), for amplification of alien
RNA in 100 ng samples compared with alien RNA alone
ranged between 0.16~2.37. When the samples were
diluted 5-fold, increases of the Ct value, ranged between -
0.14~0.92, indicating that the inhibition of qRT-PCR by
inhibitors was significantly reduced by simply diluting the
experimental RNA samples (Figure 1), but was not
reduced to an acceptable level in some samples.
Pearson's correlation analysis between the OD 260/230
ratios and ΔCt values resulted in a Pearson's r of -0.2420,
r2 of 0.0586, and a p value of 0.175, indicating no statisti-
cally significant linear relationship between the two vari-
ables (Table 3). Data shown here suggest that an alien
RNA control, but not the OD 260/230 ratio, is an direct
and specific way for the detection of qRT-PCR inhibitors
Table 1: Putative reference genes evaluated.
Gene GenBank accession 
number
Name Function Genomic localization Gene Aliases IMAGE
B2M NM_004048 Beta-2-microglobulin Beta-chain of major 
histocompatibility 
complex
class I molecules
15q21-q22 51940
GAPDH NM_002046 Glyceraldehyde-3-
phosphate 
dehydrogenase
Oxidoreductase in 
glycolysis and 
gluconeogenesis
12p13 G3PD 510510
HMBS NM_000190.3 Hydroxymethyl-bilane 
synthase
Heme synthesis, 
porphyrin metabolism
11q23 245564
HPRT1 NM_000194.1 Hypoxanthine 
phosphoribosyl-
transferase 1
Purine synthesis in 
salvage pathway
Xq26 HGPRT 345845
SDHA NM_004168.2 Succinate dehydrogenase 
complex, subunit A
Electron transporter in 
the TCA cycle and 
respiratory chain
5p15 FP; SDH2; SDHF 375812
UBC NM_021009.3 Ubiquitin C Protein degradation 12q24 510582BMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
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Table 2: Details of primers and amplicons for the 6 evaluated genes.
Gene Primer Sequence (5' → 3') Genomic Position Amplicon Length correlation coeffi-
cients (R2)
qRT-PCR Efficiency 
(%)
B2M Forward CTCCGTGGCCTTAGC
TGTG
1st Exon 69 bp 0.998 90.1
Reverse TTTGGAGTACGCTGG
ATAGCCT
1st/2nd exon
GAPDH Forward TGCACCACCAACTGC
TTAGC
7th Exon 87 bp 0.997 92
Reverse GGCATGGACTGTGGT
CATGAG
7th/8th exon
HMBS Forward TGCAACGGCGGAAGA
AAA
1st/2nd Exon 113 bp 0.998 91.0
Reverse ACGAGGCTTTCAATG
TTGCC
3rd exon
HPRT1 Forward TGACACTGGCAAAAC
AATGCA
6th Exon 94 bp 0.997 94.9
Reverse GGTCCTTTTCACCAG
CAAGCT
6th/7th exon
SDHA Forward TGGGAACAAGAGGGC
ATCTG
2nd Exon 86 bp 0.996 87.8
Reverse CCACCACTGCATCAA
ATTCATG
3rd exon
UBC Forward CGGTGAACGCCGATG
ATTAT
1st Exon 124 bp 0.994 88.4
Reverse ATCTGCATTGTCAAG
TGACGA
1st/2nd exon
QRT-PCR inhibitor detection in all samples Figure 1
QRT-PCR inhibitor detection in all samples. ΔCt for amplification of alien RNA in samples of 100 ng and 20 ng RNA 
respectively were compared with that of Alien RNA alone. Each sample was spiked with 105 copies of alien RNA transcripts.
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in RNA samples. Thus, the selection of samples in this
study was based on the quantitative assessment of qRT-
PCR inhibitors using an alien control RNA. Samples with
a ΔCt value higher than the 75th percentile of all the sam-
ples, namely 0.675, were excluded from the analyses for
the determination of suitable reference genes. For paired
tissues, both tissues were excluded from the analysis if the
ΔCt value of one of them exceeded the cutoff value.
There is a variety of inhibitors potentially affecting the
efficiency of qRT-PCR reactions which may be co-purified
with RNA samples, depending on the source of starting
material and the methods of extraction. Tissues are among
the common sample types known to contain inhibitors
like collagen [30]. Inhibitors from experimental reagents
include phenol, ethanol, guanidine, EDTA and others
[23]. Thus, it is important to assess the existence of qRT-
PCR inhibitors in RNA samples from tissues prior to the
qRT-PCR assay.
We found no significant correlation between the OD 260/
230 ratio and the level of qRT-PCR inhibitors in RNA sam-
ples. Moreover, it has been shown that some inhibitors
may directly bind to nucleotides [31]. Therefore, whether
a modification of the RNA extraction procedure or a repu-
rification of RNA samples will reduce the level of qRT-PCR
inhibitors needs further validation.
Presence of contaminating DNA in standards and purified 
RNA samples
RT negative reactions for standards confirmed completely
removal of plasmid DNA. There were PCR amplifications
in RT negative reactions of B2M and GAPDH in two sam-
ples with Ct values much lower than those of RT positive
reactions of the same samples, indicating a negligible
copy number of amplified contaminating DNA (see addi-
tional file 8). There were no PCR amplifications of the
other four genes in RT negative reactions for the samples.
Standard curves and qRT-PCR efficiency of each primer 
pair
The qRT-PCR efficiency of each primer pair was deter-
mined by serial dilutions of homologous external RNA of
each gene. Homologous RNA standards are most suitable
for two reasons [32]: (i) RNA standards (as opposed to
DNA) must be used to control the variability during the
RT step; (ii) homologous external RNA standards share
the same primer binding site as the native RNA and has
the same intervening sequence, and hence are most likely
to have the same or very similar RT and PCR efficiencies.
DNA standards, such as plasmid DNA and PCR fragments
are generally used, assuming that the RT variability is neg-
ligible, because the subsequent PCR assays are generally
used to calculate PCR efficiency. The use of DNA stand-
ards can be an accurate estimation of qRT-PCR efficiency
only when there is minimal RT variability. It is worth not-
ing that in vitro transcribed RNA from PCR products is not
the same as full length mRNA, concerning secondary or
tertiary mRNA structures which may affect RT efficiency.
Thus, for in vitro transcribed RNA, it is important to have
sequences upstream and downstream from the amplified
sequence identical or similar to the "natural" target. The
use of one-step qRT-PCR in this study further reduced the
variability of qRT-PCR by lowering the contamination risk
because of circumventing the need to open the reaction
tubes between RT and PCR steps. To adapt the back-
ground of the standards to the native RNA samples, each
dilution of the standards was spiked with 20 ng E. coli
total RNA consisting of the same amount of nucleic acids
as the native RNA samples.
Efficiency of qRT-PCR (E) of primer pairs ranged from
87.8% to 94.9%, and correlation coefficients (R2) ranged
from 0.994 to 0.998 (Table 2). The amplification of alien
RNA transcripts among standards and 20 ng native RNA
samples was at a similar level, thus indicating analogical
qRT-PCR efficiency (Figure 2).
Expression levels of candidate reference genes
According to the average copy number of each gene in 20
ng purified total RNA of each sample, the six tested genes
belong to various abundance classes, with an approxi-
mately 10,000-fold expression difference between the
most abundant (B2M) and the rarest (UBC) transcript.
The expression levels for individual genes were also differ-
ent among different sample panels. Four out of six genes
showed an expression pattern in cell lines > tumoral tis-
sues > non-tumoral tissues, SDHA showed an expression
Table 3: Pearson's correlation analysis between the existence of qRT-PCR inhibitors and OD 260/230.
median 75th Mean STD Normality test Pearson's correlation coefficient
ΔCt* 0,49 0.675 0.47 0.26 P ≥ 0.20 r = -0.2420 (r2 = 0.0586), p = 0.175
OD 260/230 1.49 1.965 1.49 0.48 P ≥ 0.15
Both of the variables were determined to be approximately normally distributed prior to the calculation of Pearson's correlation coefficient. * 
Amplification of alien RNA in 20 ng RNA samples compared with alien RNA alone; OD260/230: the ratio of optical density (OD) at wavelength of 
260 nm to that at 230 nm. 75th: 75th percentile.BMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
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pattern in cell lines > non-tumoral tissues ≈ tumoral tis-
sues, and B2M showed an expression pattern in tumoral
tissues > non-tumoral tissues > cell lines (Figure 3).
Expression stability of putative reference genes
The data obtained for each sample and each reference
gene were analyzed using both geNorm and NormFinder
[1,33].  GeNorm  provides a ranking of the tested genes
based on the reference gene stability measure M which is
defined as the average pair-wise variation of a particular
gene compared with all other control genes. Genes with
higher M values have greater variations of expression.
Additionally, the assessment of the pair-wise variations
(Vn/n+1) between each combination of sequential normal-
ization factors allows the identification of the optimal
number of reference genes. NormFinder, whose strategy is
rooted in a mathematical model of gene expression, pro-
vides a ranking of the tested genes based on a direct meas-
ure of both overall expression variation and the variation
between sample subgroups of candidate reference genes.
The stability of genes was shown as stability value, and
genes with lower stability values have higher expression
stability. NormFinder has been reported to show relatively
low sensitivity towards co-regulation of the candidate nor-
malization genes [33].
The analysis by geNorm suggested that all studied genes
reached a high expression stability with low M values
(Table 4 and 5), below the default limit of M = 1.5[1]. The
optimal reference genes for normalizing gene expression
data between paired tumoral and non-tumoral liver tis-
sues were HMBS and GAPDH (Table 4; Figure 4). HMBS,
GAPDH and UBC were identified to be suitable for the
normalization of gene expression data among tumor tis-
sues. The combination of HMBS, B2M,  SDHA  and
GAPDH  was suitable for normalizing gene expression
data among five liver cancer cell lines, yielding a V4/5 value
of 0.175, which is close to the cutoff value 0.15. The rea-
son why there was no low enough V value in cell lines may
be due to the limited number of cell lines or candidate ref-
erence genes included in the evaluation.
The results of the analysis by NormFinder appeared to be
identical to the one determined using geNorm  in each
sample panel, except for the position of two genes with
close stability, GAPDH  and SDHA, whose ranking was
inverted in paired tissues (Table 4). Interestingly, the sta-
ble value of the best combination of two genes deter-
mined by NormFinder for paired tissues was slightly higher
than that of HMBS  alone (Table 4), indicating HMBS
alone may be sufficient as reference gene for expression
studies in paired tissues.
When comparing the data of the paired tissue group in
which 10 tissue RNA samples with high inhibitory sub-
stances were excluded, a higher stability of each gene, and
a higher similarity between the two algorithms became
evident (Table 4; Figure 4), indicating that the existence of
qRT-PCR inhibitors in RNA samples can increase the var-
iation of qRT-PCR assay.
QRT-PCR inhibitor detection in standards and several RNA samples Figure 2
QRT-PCR inhibitor detection in standards and several RNA samples. ΔCt for amplification of alien RNA in standards 
spiked with 20 ng E. coli total RNA and 20 ng RNA from several RNA samples were compared with that of alien RNA alone. 
The tissue samples contained relatively high and low abundance of qRT-PCR inhibitor existence as determined by the qRT-
PCR detection among all samples. Each sample was spiked with 105 copies of alien RNA transcripts.
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Expression levels of 6 putative reference genes in different sample panels Figure 3
Expression levels of 6 putative reference genes in different sample panels. Average copy number of each gene in 20 
ng of purified RNA samples was transferred on a base-10 logarithmic scale. An approximately 10,000-fold expression differ-
ence is apparent between the most abundant (B2M) and the rarest (UBC) transcript.
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Table 4: Reference genes ranked in order of increasing expression stability in paired liver tissues*.
paired tissues A (n = 22) Paired tissues B (n = 32)
geNorm M value NormFinder Stability value geNorm M value NormFinder Stability value
B2M 0.799 B2M 0.149 B2M 0.826 UBC 0.207
HPRT1 0.658 HPRT1 0.105 HPRT1 0.816 SDHA 0.203
UBC 0.654 UBC 0.101 UBC 0.771 HPRT1 0.164
SDHA 0.598 GAPDH 0.068 SDHA 0.711 B2M 0.159
GAPDH 0.566 SDHA 0.052 GAPDH 0.692 GAPDH 0.145
HMBS 0.514 HMBS 0.021 HMBS 0.629 HMBS 0.084
HMBS-GAPDH 0.417 HMBS-SDHA 0.033 HMBS-SDHA 0.489 HMBS-B2M 0.079
Paired tissues A: paired tumoral and non-tumoral tissues left after the exclusion of RNA samples with relatively high amount of inhibitors; Paired 
tissues B: all paired tissues. *Increases from top to bottom.BMC Cancer 2008, 8:350 http://www.biomedcentral.com/1471-2407/8/350
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It is worth noting that clonal variation that has been
described to occur in HCC [34], might induce bias in gene
expression studies. While genomic heterogeneity may
interfere with gene expression studies aimed at identifying
a malignant genotype, this phenomenon should be of less
importance for the selection of reference genes which are
constitutively expressed and are generally involved in
basic functions needed for the sustenance of the cell.
As shown in Table 6, major differences were evident in the
ranking order and gene stability of the candidate genes in
paired tissues compared to a similar study previously pub-
lished by Kim et al. [35]. UBC was ranked as the most sta-
Table 5: Reference genes ranked in order of increasing expression stability in tumoral tissues and cell lines*.
Tumoral tissues Cell lines
geNorm M value NormFinder Stability value geNorm M value NormFinder Stability value
B2M 1.091 B2M 0.661 UBC 1.277 UBC 0.791
SDHA 0.953 SDHA 0.517 HPRT1 1.112 HPRT1 0.652
HPRT1 0.863 HPRT1 0.448 GAPDH 1.002 GAPDH 0.457
UBC 0.837 UBC 0.393 SDHA 0.921 SDHA 0.408
GAPDH 0.763 GAPDH 0.294 B2M 0.887 B2M 0.321
HMBS 0.676 HMBS 0.060 HMBS 0.857 HMBS 0.272
HMBS-GAPDH 0.461 - - HMBS-SDHA 0.620 - -
* Increases from top to bottom
Determination of the optimal number of reference genes for paired tumoral and non-tumoral tissues, tumor tissues and cell  lines separately Figure 4
Determination of the optimal number of reference genes for paired tumoral and non-tumoral tissues, tumor 
tissues and cell lines separately. Pair-wise variations (Vn/n+1) between every combination of sequential normalization fac-
tors were calculated to determine the minimum number of reference genes required for accurate normalization in different 
sample panels (Paired tissues A: paired tumoral and non-tumoral tissues left after the exclusion of RNA samples with relatively 
high amount of inhibitors; Paired tissues B: all paired tissues). The cutoff value below which the inclusion of an additional refer-
ence gene does not result in a significant improvement of normalization, was set at 0.15 (arrowhead = minimum number of ref-
erence genes for normalization).
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bly expressed gene in the previous study, but was ranked
as the fourth using both geNorm and NormFinder in our
study. In addition, the M values for the candidate refer-
ence genes were much lower in our study, thus indicating
a high reliability of the data. The notably higher stability
of putative reference genes in our study may be due to the
following:  (i)  matching tumoral tissue with the non-
tumoral tissue from the same patient may have reduced
the noise deriving from diversity of gene expression
among individuals; (ii) the integrity of RNA was assessed
and controlled using Agilent Bioanalyzer; (iii) qRT-PCR
inhibitor was maintained at an acceptable level in all
standards and samples; and (iv) qRT-PCR efficiency was
determined for each primer pair.
Conclusion
Of six genes studied, HMBS was found to be the single
best reference gene for expression studies in HCC. The
appropriate choice of combination of more than one ref-
erence gene to improve qRT-PCR accuracy depends on the
kind of liver tissues or cells under investigation. Quantita-
tive assessment and control of qRT-PCR inhibitors using
an external RNA control can reduce the variation of qRT-
PCR assay and facilitate the evaluation of gene stability.
Our results may facilitate the choice of reference genes for
expression studies in HCC.
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Table 6: Reference genes ranked in order of increasing 
expression stability in the current study and the study of Kim et 
al. [35].
Current study* Study of Kim et al.
Rank Genes M value Genes M value
6 B2M 0.799 B2M 2.60
5 HPRT1 0.658 RPL13A 2.50
4 UBC 0.654 GAPDH 2.43
3 SDHA 0.598 HPRT1 2.26
2 GAPDH 0.566 HMBS 2.18
1 HMBS 0.514 UBC 2.17
HMBS-GAPDH 0.417 UBC-HMBS 1.02
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